West Point Appoints Cannabinoid Expert Andrew Davies as Advisor
April 8, 2014
Vancouver, British Columbia, April 8 2014: West Point Resources Inc. (TSX Venture: WPO) (the “Company”) is pleased to announce it has added Andrew Davies, one of Europe’s foremost experts in cannabinoid research as an Advisor to the Company.
Andrew Davies is the CEO of STI Pharmaceuticals Ltd., a leading cannabinoid research company based in London, England. STI Pharmaceuticals develops investigational products for a wide range of clinical research.
Andrew has over 25 years of experience in the pharmaceutical industry and was instrumental in securing the first US IND for synthetic Cannabidiol (CBD) at Yale University. Andrew is a Chartered Mechanical Engineer and holds a BEng from the University of Liverpool and an International Executive MBA from the University of Middlesex Business School, London. Andrew is a sought after speaker at cannabinoid conferences globally.
Rav Mlait, president and CEO states: “We are seeing a significant ramp up in the use of Cannabidiol (CBD) for a wide range of health ailments. CBD is a non-psychoactive natural compound that has been shown in scientific and clinical studies to possess beneficial properties in the treatment of various conditions, including epilepsy, seizures, arthritis, diabetes, MS, PTSD, skin cancer and other neurological disorders. Recent headlines from several U.S. states, where advocates are demanding that laws be changed to allow easier access to CBD for the treatment of epileptic seizures, are capturing the attention of researchers, legislators and investors worldwide. Several U.S. states have recently introduced or passed bills to legalize the use of CBD in the treatment of epilepsy and other debilitating conditions. We see several potential business opportunities related to the research and development of CBD. Expert researchers like Andrew Davies have been on the front line of CBD development for many years.”
At this time, there are no transactions in place, nor is there any assurance that a transaction will be concluded in the future.
We seek Safe Harbor.
On behalf of the Board of Directors
President and CEO
West Point Resources Inc.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, Cannabix Technologies Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.